Jen Herbach net worth
Quick answer
Jen Herbach's estimated net worth is $6.67M (range $4.67M – $10.0M) as of 2026. Jen Herbach is Founder at Adventris Pharmaceuticals. Adventris Pharmaceuticals valuation.
Jen Herbach is Founder at Adventris Pharmaceuticals (YC W23). Independent Entrepreneurial Check model estimate from public YC data.
At a glance
- Company status: Active
- Region: United States of America
- Industries: Healthcare, Drug Discovery and Delivery
- Team size: 7
- Website: https://adventris.com
Who is Jen Herbach?
Jen Herbach is a founder at Adventris Pharmaceuticals and was part of Y Combinator's Winter 2023 cohort.
Highlights:
- Y Combinator W23
- Adventris Pharmaceuticals
About Adventris Pharmaceuticals
Adventris makes cancer vaccines. Our platform solves the problem of targeting poorly immunogenic oncogenes. Our first "off-the-shelf" vaccine targets KRAS, the most common cancer oncogene. In the long run, we envision a world where every adult receives our pan-cancer vaccines annually – preventing the majority of cancer deaths.
If you are interested in learning more about our approach to treat and prevent...
FAQ: Jen Herbach net worth and Adventris Pharmaceuticals valuation
What is Jen Herbach's net worth?
Jen Herbach's estimated net worth is $6.67M (range $4.67M – $10.0M) as of 2026. Jen Herbach is Founder at Adventris Pharmaceuticals. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.
What is Adventris Pharmaceuticals valuation?
Adventris Pharmaceuticals's estimated valuation on Entrepreneurial Check is $20.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.
What is Jen Herbach's role?
Jen Herbach is Founder at Adventris Pharmaceuticals, a Y Combinator-backed startup (batch W23).